SCHEMBL7063281

SCHEMBL7063281

C[C@@H](C(=O)O)N1C=CCC[C@H](N2C(=O)c3ccccc3C2=O)C1=O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
ALDH1A1 P00352 3/20 0.37
DDB1 Q16531 2/20 0.37
CRBN Q96SW2 2/20 0.37
CHRM2 P08172 1/20 0.37
OPRM1 P35372 1/20 0.37
IKZF3 Q9UKT9 1/20 0.37
CYP1A2 P05177 1/20 0.37
TSHR P16473 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HTT P42858 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 3/20 0.35
KMT2A Q03164 2/20 0.34
NPC1 O15118 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7063373 0.88 TP53 (0.38) LMNAALDH1A1DDB1CRBNCHRM2
SCHEMBL18366039 0.76 DDB1 (0.44) ALDH1A1DDB1CRBNCHRM2OPRM1
SCHEMBL7064754 0.76 CA12 (0.45) ALDH1A1DDB1CRBNCHRM2OPRM1
SCHEMBL7064747 0.76 CA12 (0.45) ALDH1A1DDB1CRBNCHRM2OPRM1
SCHEMBL7340893 0.74 ALDH1A1 (0.44) LMNAALDH1A1DDB1CRBNCHRM2
SCHEMBL7062412 0.73 DPP4 (0.36) TSHRTDP1KMT2A
SCHEMBL7501387 0.68 ALOX15 (0.43) LMNAALDH1A1TSHRTDP1HTT
SCHEMBL8212856 0.68 ALOX15 (0.43) LMNAALDH1A1TSHRTDP1HTT
SCHEMBL125972 0.66 LMNA (0.71) LMNAALDH1A1TSHRTDP1HTT
SCHEMBL478339 0.66 LMNA (0.71) LMNAALDH1A1TSHRTDP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0728746-B1 Azepinone compounds useful in the inhibition of ACE and NEP BRISTOL MYERS SQUIBB CO (US) 2003-05-28 EP disclosed
US-6143886-A CYCLOPROPYL-SUBSTITUTED AZEPINONE COMPOUNDS WHICH ARE USEFUL EITHER AS SELECTIVE ANGIOTENSIN CONVERTING ENZYME INHIBITORS, OR AS DUAL INHIBITORS OF BOTH ANGIOTENSIN CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE BRISTOL-MYERS SQUIBB CO. (US) 2000-11-07 US disclosed
US-5994537-A Process for preparing azepinone compounds useful in the inhibition of ACE and NEP BRISTOL-MYERS SQUIBB CO. (US) 1999-11-30 US disclosed
US-5587375-A TREATING BLOOD PRESSURE, INTRAOCULAR PRESSURE, CARDIOVASCULAR DISORDERS, GLAUCOMA, AND RENAL DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 1996-12-24 US disclosed
EP-0728746-A1 Azepinone compounds useful in the inhibition of ACE and NEP BRISTOL-MYERS SQUIBB COMPANY (US) 1996-08-28 EP disclosed